Olsalazine Versus Sulfasalazine in Mild to Moderate Childhood Ulcerative Colitis
George D. Ferry(Baylor College of Medicine), Bobbette A. Jones(Texas Children's Hospital), Stephen C. Fiedorek(Texas Children's Hospital), Eric Hassall(University of British Columbia), Robert M. Issenman(Texas Children's Hospital), Barbara S. Kirschner(Comer Children's Hospital), William J. Byrne(Texas Children's Hospital), Harland S. Winter(Massachusetts General Hospital), Danièl Thomas(Unknown), Richard J. Grand(Boston Children's Hospital), Jay A. Perman(University of Louisville), Frederic Daum(Texas Children's Hospital), John B. Watkins(Children's Hospital of Wisconsin), James E. Heubi(Cincinnati Children's Hospital Medical Center), Martin H. Ulshen(Duke Medical Center), Anne M. Griffiths(Children's Hospital of Wisconsin), Joyce D. Gryboski(Loma Linda University), John Vanderhoof(Texas Children's Hospital)
Cited by 66
Related Papers
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
|Gastroenterology|2006|872
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report
|PEDIATRICS|2010|870
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)
|Journal of Pediatric Gastroenterology and Nutrition|2009|736